Print preview VALIDITY EXPIRED This page was not yet approved. Publications |
2023
from data base, 2024. VII. 08. |
Harsing Laszlo G., Timar Julia, Miklya Ildiko: Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24: (17) 13334 type of document: Journal paper/Article language: English URL |
2022
from data base, 2024. VII. 08. |
Harsing Laszlo, Knoll Joseph, Miklya Ildiko: Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23: (15) 8543 type of document: Journal paper/Article number of independent citations: 3 language: English URL |
2020
from data base, 2024. VII. 08. |
Knoll J, Zelena D, Timar J, Baghy K, Mervai Z, Miklya I: Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response, BEHAVIOURAL BRAIN RESEARCH 378: 112290 type of document: Journal paper/Article language: English URL |
2017
from data base, 2024. VII. 08. |
Knoll J, Baghy K, Eckhardt S, Ferdinandy P, Garami M, Harsing LG Jr, Hauser P, Mervai Z, Pocza T, Schaff Z, Schuler D, Miklya I: A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain, LIFE SCIENCES 182: pp. 57-64. type of document: Journal paper/Article number of independent citations: 3 language: English URL |
2016
from data base, 2024. VII. 08. |
Miklya I: The significance of selegiline/(−)-deprenyl after 50 years in research and therapy (1965–2015), MOLECULAR PSYCHIATRY 21: (11) pp. 1499-1503. type of document: Journal paper/Review paper number of independent citations: 25 language: English URL |
2016
from data base, 2024. VII. 08. |
Knoll J, Miklya I: Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP), LIFE SCIENCES 167: pp. 32-38. type of document: Journal paper/Article number of independent citations: 6 language: English URL |
2011
from data base, 2024. VII. 08. |
Miklya I: The Knoll-Concept to Decrease the Prevalence of Parkinson's Disease, In: David, I Finkelstein (szerk.) Towards New Therapies for Parkinson's Disease, IntechOpen (2011) pp. 77-100. type of document: Part of book/Szaktanulmány (to be translated) language: English URL |
2000
from data base, 2024. VII. 08. |
Knoll J, Miklya I, Knoll B, Dalló J: Sexual Hormones Terminate in The Rat: The Significantly Enhanced Catecholaminergic/serotoninergic Tone in The Brain Characteristic to The Post-weaning Period, LIFE SCIENCES 67: (7) pp. 765-773. type of document: Journal paper/Article number of independent citations: 30 language: English URL |
1999
from data base, 2024. VII. 08. |
Knoll J, Yoneda F, Knoll B, Ohde H, Miklya I: (-)1-(Benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain, BRITISH JOURNAL OF PHARMACOLOGY 128: (8) pp. 1723-1732. type of document: Journal paper/Article number of independent citations: 16 language: English URL |
1996
from data base, 2024. VII. 08. |
Knoll J, Miklya I, Knoll B, Markó R, Kelemen K: (-)Deprenyl and (-)1-phenyl-2-propylaminopentane, (-)PPAP, act primarly as potent stimulants of actionpotential-transmitter release coupling in the catecholaminergic neurons, LIFE SCIENCES 58: (10) pp. 817-827. type of document: Journal paper/Article number of independent citations: 27 language: English URL |
| Number of independent citations to these publications: | 110 |
|
|